Skip to content

Pizo

Active
Private limited companyfounded 2023active for 3 yearsGrote Molenweg 76, 3020 Herent, BelgiumKBO/BCE: BE 0803.943.522
Summary

Pizo has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€12,024) and a net result of -€23,925. Equity has been shrinking by about 100% per year since 2023. Its solvency ranks better than 5% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 13-07-2023 Normal situation
Activity
Specialist medical practice NACE 86220and 3 others
Establishment unit
2.347.658.534 3020 Herent, since 13-07-2023
Financial year end
31 December
Peppol
Reachable since 19-11-2025

Board and ownership

Board

Financial position

52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
-€23,322
Loss
€23,925
Equity
-€12,024
Total assets
€6,383
▼ 81.0%
  • Negative equity on 31-12-2025
Turnover not published (micro format)
Score breakdownraises riskCapped at 59: negative equityNegative equity -€12,024Loss of €23,925 (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €6,383Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 4% of micro companies in human health (NACE 86)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 0-60
equity -188.4% of total assets
Liquidity 47-19
short-term debt 288.4% · cash 37.6%
Profitability 0-100
return on assets -374.8%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.4%▲ +0.3 percentage points vs 04-2026highest value 06-2026: 0.4%● unchanged vs 05-2026highest value 07-2026: 0.4%● unchanged vs 06-2026highest value 08-2026: 0.4%● unchanged vs 07-2026highest value 09-2026: 0.2%▼ -0.2 percentage points vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026
No credit on open account
Liquidity is insufficient, with a current ratio of 0.35 (1.55 in 2024), below 1. Short-term debt is 288.4% and cash 37.6% of total assets. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 1% of them on solvency, 15% on liquidity, 1% on profitability and 1% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €6,383
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Negative equity -€12,024
NBB · annual accounts
raises risk · Loss of €23,925 (financial year 2025)
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
232425
2023 to 2025 · latest year -€12,024
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-04-2026, 109 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
109 days early
2024
94 days early
2023
47 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 83 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 April (3 of the last 3 accounts filed within 48 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€12,024 View
  • Caution: Lower solvency than 95% of companies in human healthsector median 63.0% · 20,700 companies -188.4% View

Recent changes

  1. · Gazette deed Registered office moved from Leuven to Herent
  2. · Gazette deed IncorporationStarting capital €150 · Appointment: Zoë Pironet (director)
All 7 events

Comparable companies

These companies have the same main activity as Pizo: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €5,000 and €8,100, founded between 2020 and 2025.

CompanyTotal assetsGross margin
Pizo Herent€6,383-€23,322
Dr. Tine Grégoir Bierbeek€6,163-€1,430
Dokter Lina Del Favero Glabbeek€7,475-€2,531
WeFace Evergem€7,381-€5,526
Dr. Matic Milica Schaarbeek€5,000-€1,601
Pneumologen Maaseik Maaseik€5,534€751
Dr. Paul Hendrickx Keerbergen€8,103-€19,413
Full comparison

Key facts about Pizo

What is the company number of Pizo?
The company number of Pizo is 0803.943.522. The VAT number is the same number with BE in front: BE 0803.943.522.
Where is Pizo based?
The registered office is at Grote Molenweg 76, 3020 Herent.Company details
What does Pizo do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Pizo?
The legal form of Pizo is Private limited company (BV).
When was Pizo founded?
Pizo was founded on 13-07-2023.
Is Pizo still active?
Yes, Pizo is an active enterprise in the KBO register.
What is the turnover of Pizo?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is Pizo profitable?
In financial year 2025, Pizo made a loss of €23,925.
Where can I find the annual accounts of Pizo?
Pizo filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Pizo due?
Pizo must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.